Literature DB >> 35804236

150-cm Versus 200-cm Biliopancreatic Limb One-Anastomosis Gastric Bypass: Propensity Score-Matched Analysis.

Thibaud Bertrand1,2, Claire Rives-Lange1,3, Anne-Sophie Jannot1,4,5,6, Clement Baratte1,2, Flore de Castelbajac1,3, Estelle Lu4, Sylvia Krivan7, Maud Le Gall1,8, Claire Carette1,3, Sebastien Czernichow1,3,9, Jean-Marc Chevallier1,2, Tigran Poghosyan10,11,12.   

Abstract

BACKGROUND: It has been suggested that shortening the length of the biliopancreatic limb (BPL) to 150 cm in one anastomosis gastric bypass (OAGB) would reduce nutritional complication rates without impairing weight loss outcomes. The aim of this study is to compare patients who underwent OAGB with a 200-cm BPL (OAGB-200) to patients with OAGB with a 150-cm BPL (OAGB-150) in terms of weight loss and late morbidity.
METHODS: This is a monocentric retrospective matched cohort study including patients with a body mass index between 35 and 50 kg/m2 who underwent an OAGB-150 or an OAGB-200. Patients were matched 1:1 based on age, sex, and body mass index, prior to bariatric surgery.
RESULTS: In total, 784 patients who underwent OAGB were included (OAGB-150 n = 392 and OAGB-200 (n = 392). There was no significant difference in terms of early morbidity. Regarding late morbidity in patients with an OAGB-150, significantly lower rates for marginal ulcer (OR = 0.4, CI 95% [0.2; 0.8], p = 0.006), incisional hernia (OR = 0.5, CI 95% [0.3; 1], p = 0.041), and bowel obstruction (OR = 0.3, CI 95% [0.1; 0.9], p = 0.039) were reported. Likewise, regarding late nutritional deficiencies, post-OAGB-150, a significantly lower number of patients with hypoalbuminemia (OR = 0.3, CI 95% [0.2; 0.7], p = 0.006), low vitamin B9 (OR = 0.5, CI 95% [0.2; 1], p = 0.044), and low ferritin (OR = 0.5, CI 95% [0.3; 0.8], p = 0.005) were observed. There was no significant difference in the percentage of excess BMI loss at 1, 2, 3, 4, and 5 years.
CONCLUSION: Compared to OAGB-200 in patients with BMI ≤ 50 kg/m2, OAGB-150 results in fewer nutritional deficiency rates long term, without impairing weight loss.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  150-cm biliopancreatic limb length; 200-cm biliopancreatic limb; Mini gastric bypass; Nutritional deficiencies; One-anastomosis gastric bypass; Weight loss

Mesh:

Year:  2022        PMID: 35804236     DOI: 10.1007/s11695-022-06203-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


  14 in total

1.  A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure.

Authors:  Gurvinder S Jammu; Rajni Sharma
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

2.  The mini-gastric bypass: experience with the first 1,274 cases.

Authors:  R Rutledge
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

3.  Yet Another Mortality with a Biliopancreatic Limb of > 200 cm with One Anastomosis Gastric Bypass.

Authors:  Kamal K Mahawar
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

4.  One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy.

Authors:  Jean Marc Chevallier; Gustavo A Arman; Martino Guenzi; Cedric Rau; Mathieu Bruzzi; Nathan Beaupel; Frank Zinzindohoué; Anne Berger
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

5.  Malabsorption and intestinal adaptation after one anastomosis gastric bypass compared with Roux-en-Y gastric bypass in rats.

Authors:  Jean-Baptiste Cavin; Eglantine Voitellier; Françoise Cluzeaud; Nathalie Kapel; Jean-Pierre Marmuse; Jean-Marc Chevallier; Simon Msika; André Bado; Maude Le Gall
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-14       Impact factor: 4.052

6.  One Anastomosis Gastric Bypass with a Biliopancreatic Limb of 150 cm: Weight Loss, Nutritional Outcomes, Endoscopic Results, and Quality of Life at 8-Year Follow-Up.

Authors:  Arnaud Liagre; Tarek Debs; Radwan Kassir; Alain Ledit; Gildas Juglard; Mael Chalret du Rieu; Andrea Lazzati; Francesco Martini; Niccolo Petrucciani
Journal:  Obes Surg       Date:  2020-11       Impact factor: 4.129

7.  Need for Intensive Nutrition Care After Bariatric Surgery.

Authors:  Cécile Bétry; Emmanuel Disse; Cécile Chambrier; Didier Barnoud; Patrick Gelas; Sandrine Baubet; Martine Laville; Elise Pelascini; Maud Robert
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-07-11       Impact factor: 4.016

8.  Effect of One Anastomosis Gastric Bypass on Haematinics, Vitamin D and Parathyroid Hormone Levels: a Comparison Between 150 and 200 cm Bilio-Pancreatic Limbs.

Authors:  Islam Omar; Miraheal Adadzewa Sam; Maya Elizabeth Pegler; Emma Jane Bligh Pearson; Maureen Boyle; Kamal Mahawar
Journal:  Obes Surg       Date:  2021-02-17       Impact factor: 4.129

Review 9.  Effect of Biliopancreatic Limb Length on Weight Loss, Postoperative Complications, and Remission of Comorbidities in One Anastomosis Gastric Bypass: a Systematic Review and Meta-analysis.

Authors:  Erfan Tasdighi; Maryam Barzin; Kamal K Mahawar; Farhad Hosseinpanah; Amir Ebadinejad; Nazanin Taraghikhah; Anahita Mansoori; Alireza Khalaj; Mahtab Niroomand; Majid Valizadeh; Behnaz Abiri
Journal:  Obes Surg       Date:  2022-01-29       Impact factor: 4.129

10.  MGB-OAGB: Effect of Biliopancreatic Limb Length on Nutritional Deficiency, Weight Loss, and Comorbidity Resolution.

Authors:  Anmol Ahuja; Om Tantia; Ghanshyam Goyal; Tamonas Chaudhuri; Shashi Khanna; Anshuman Poddar; Sonam Gupta; Kajari Majumdar
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

View more
  1 in total

1.  Reply to Letter to the Editor: France and One Anastomosis Gastric Bypass (OAGB): a "Witch Hunt".

Authors:  Tigran Poghosyan; Thibaud Bertrand; Claire Rives-Lange; Sylvia Krivan; Clement Baratte; Maude Le Gall; Sebastien Czernichow; Jean-Marc Chevallier
Journal:  Obes Surg       Date:  2022-09-06       Impact factor: 3.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.